NNVC vs NRIX

NanoViricides, Inc. vs Nurix Therapeutics, Inc. — Valuation Comparison 2026

NNVC

Biotechnology
NanoViricides, Inc.
Quality
4.3
out of 10
Value Trap
30
LOW
Price
$1.86
Last close
Models
7/13
Active
VS

NRIX

Biotechnology
Nurix Therapeutics, Inc.
Quality
6.4
out of 10
Value Trap
12
SAFE
Price
$17.67
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType NNVC Fair ValueNNVC Upside NRIX Fair ValueNRIX Upside
Bayesian DCF Intrinsic $0.57 -69.1% $4.91 -72.2%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $1.00 -46.4% $4.75 -73.1%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for NNVC vs NRIX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

NNVC vs NRIX — Which Stock Is More Undervalued?

NRIX scores higher with a 6.4/10 quality rating vs NNVC's 4.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing NanoViricides, Inc. (NNVC) and Nurix Therapeutics, Inc. (NRIX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

NNVC currently trades at $1.86 with a QOC of 4.3/10, while NRIX trades at $17.67 with a QOC of 6.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).